Literature DB >> 17384144

Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury.

Jacqui M Marzec1, Jason D Christie, Sekhar P Reddy, Anne E Jedlicka, Hue Vuong, Paul N Lanken, Richard Aplenc, Tae Yamamoto, Masayuki Yamamoto, Hye-Youn Cho, Steven R Kleeberger.   

Abstract

We recently used positional cloning to identify the transcription factor Nrf2 (NF-E2 related factor 2) as a susceptibility gene in a murine model of oxidant-induced acute lung injury (ALI). NRF2 binds to antioxidant response elements (ARE) and up-regulates protective detoxifying enzymes in response to oxidative stress. This led us to investigate NRF2 as a candidate susceptibility gene for risk of development of ALI in humans. We identified multiple single nucleotide polymorphisms (SNPs) by resequencing NRF2 in ethnically diverse subjects, and one (-617 C/A) significantly (P<0.001) diminished luciferase activity of promoter constructs containing the SNP and significantly decreased the binding affinity (P<0.001) relative to the wild type at this locus (-617 CC). In a nested case-control study, patients with the -617 A SNP had a significantly higher risk for developing ALI after major trauma (OR 6.44; 95% CI 1.34, 30.8; P=0.021) relative to patients with the wild type (-617 CC). This translational investigation provides novel insight into the molecular mechanisms of susceptibility to ALI and may help to identify patients who are predisposed to develop ALI under at risk conditions, such as trauma and sepsis. Furthermore, these findings may have important implications in other oxidative stress related illnesses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384144     DOI: 10.1096/fj.06-7759com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  158 in total

1.  Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans.

Authors:  Ewa D Marczak; Jacqui Marzec; Darryl C Zeldin; Steven R Kleeberger; Nancy J Brown; Mias Pretorius; Craig R Lee
Journal:  Pharmacogenet Genomics       Date:  2012-08       Impact factor: 2.089

2.  Thiol redox disturbances in children with severe asthma are associated with posttranslational modification of the transcription factor nuclear factor (erythroid-derived 2)-like 2.

Authors:  Anne M Fitzpatrick; Susan T Stephenson; Graham R Hadley; Leandrea Burwell; Madhuri Penugonda; Dawn M Simon; Jason Hansen; Dean P Jones; Lou Ann S Brown
Journal:  J Allergy Clin Immunol       Date:  2011-04-22       Impact factor: 10.793

3.  Genetic variation in the Nrf2 promoter associates with defective spermatogenesis in humans.

Authors:  Bolan Yu; Huanlan Lin; Lixia Yang; Kang Chen; Haihua Luo; Jianqiao Liu; Xingcheng Gao; Xuefeng Xia; Zhaofeng Huang
Journal:  J Mol Med (Berl)       Date:  2012-05-31       Impact factor: 4.599

4.  Induction of antioxidative Nrf2 gene transcription by coffee in humans: depending on genotype?

Authors:  Ute Boettler; Nadine Volz; Nicole Teller; Larisa M Haupt; Tamara Bakuradze; Gerhard Eisenbrand; Gerhard Bytof; Ingo Lantz; Lyn R Griffiths; Doris Marko
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

5.  Genetic and pharmacologic evidence links oxidative stress to ventilator-induced lung injury in mice.

Authors:  Srinivas Papaiahgari; Adi Yerrapureddy; Swetha R Reddy; Narsa M Reddy; Jeffery M Dodd-O; Michael T Crow; Dimitry N Grigoryev; Kathleen Barnes; Rubin M Tuder; Masayuki Yamamoto; Thomas W Kensler; Shyam Biswal; Wayne Mitzner; Paul M Hassoun; Sekhar P Reddy
Journal:  Am J Respir Crit Care Med       Date:  2007-09-27       Impact factor: 21.405

Review 6.  Recent advances in genetic predisposition to clinical acute lung injury.

Authors:  Li Gao; Kathleen C Barnes
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-02-13       Impact factor: 5.464

Review 7.  Discovery and verification of functional single nucleotide polymorphisms in regulatory genomic regions: current and developing technologies.

Authors:  Brian N Chorley; Xuting Wang; Michelle R Campbell; Gary S Pittman; Maher A Noureddine; Douglas A Bell
Journal:  Mutat Res       Date:  2008-05-04       Impact factor: 2.433

Review 8.  The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.

Authors:  Prashant Deshmukh; Sruthi Unni; Gopinatha Krishnappa; Balasundaram Padmanabhan
Journal:  Biophys Rev       Date:  2016-12-06

Review 9.  The role of hyperoxia in the pathogenesis of experimental BPD.

Authors:  Bradley W Buczynski; Echezona T Maduekwe; Michael A O'Reilly
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

10.  Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.

Authors:  Rajesh K Thimmulappa; Ralph J Fuchs; Deepti Malhotra; Catherine Scollick; Kassim Traore; Jay H Bream; Michael A Trush; Karen T Liby; Michael B Sporn; Thomas W Kensler; Shyam Biswal
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.